https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/accounts-payable https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/accrued-bonuses-current https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/accrued-liabilities-current https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/accumulated-depreciation https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/additional-paid-in-capital https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/amended-reports-10-k https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/business-acquisition-equity-interests-issued-or-issuable-number-of-shares-issued https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/capital-expenditures https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/capitalized-computer-software-gross https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/cash-and-equivalents https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/cash-fdic-insured-amount https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/cash-flow-breakdown https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/common-stock-share-subscribed-but-unissued-subscriptions-receivable https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/common-stock-value https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/cover-page-shares-outstanding https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/current-assets https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/debt-conversion-converted-instrument-shares-issued https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/deferred-tax-assets-gross https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/deferred-tax-assets-inventory https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/deferred-tax-assets-net https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/deferred-tax-assets-operating-loss-carryforwards-state-and-local https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/deferred-tax-assets-other https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/defined-contribution-plan-maximum-annual-contribution-per-employee-amount https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/defined-contribution-plan-maximum-annual-contribution-per-employee-percent https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/defined-contribution-plan-maximum-annual-contributions-per-employee-percent https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/deposit-liabilities-accrued-interest https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/depreciation-and-amortization https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/effective-tax-rate https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/employee-related-liabilities-current https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/equity-issuance-dollar-amount-per-share https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/equity-issuance-per-share-amount https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/financing-cash-flow https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/furniture-and-fixtures-gross https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/gain-loss-on-disposition-of-property https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/general-and-administrative-expense https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/increase-decrease-in-employee-related-liabilities https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/increase-decrease-in-other-accrued-liabilities https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/increase-decrease-in-restructuring-reserve https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/increase-decrease-in-security-deposits https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/insider-transactions-other https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/insider-transactions-stock-options https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/insider-transactions-warrants https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/interest-expense https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/interest-paid-net https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/investing-cash-flow https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/investment-income-interest https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/investment-warrants-exercise-price https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/leasehold-improvements-gross https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/legal-settlement-proceeds https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/line-of-credit-facility-increase-decrease-for-period-net https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/loans-payable https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/minority-interest-ownership-percentage-by-parent https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/net-cash-from-financing-activities https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/net-cash-from-investing-activities https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/net-cash-from-operating-activities https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/net-change-in-cash https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/net-income https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/noncash-or-part-noncash-acquisition-noncash-financial-or-equity-instrument-consideration-warrants-issued https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/operating-cash-flow https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/operating-expenses https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/operating-income https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/other-accrued-liabilities-current https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/other-noncurrent-assets https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/other-nonoperating-income-expense https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/paid-in-kind-interest https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/payments-for-proceeds-from-investments https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/payments-for-restructuring https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/payments-to-acquire-investments https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/preferred-shares-facts https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/preferred-stock-shares-authorized https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/preferred-stock-shares-issued https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/preferred-stock-value https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/prepaid-expense-current https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/proceeds-from-contributions-from-affiliates https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/proceeds-from-sale-of-productive-assets https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/proceeds-from-stock-issued https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/property-plant-and-equipment-gross https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/property-plant-equipment https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/public-float https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/recapitalization-costs https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/research-and-development https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/research-and-development-expense-excluding-acquired-in-process-cost https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/restructuring-charges https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/restructuring-reserve https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/restructuring-reserve-accrual-adjustment https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/restructuring-reserve-settled-with-cash https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/revenue-from-grants https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/sec-comment-letters-corresp https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/sec-comment-letters-upload https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/sec-filings-10-k https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/sec-filings-10-q https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/sec-filings-15-12g https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/sec-filings-25-nse https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/sec-filings-8-a12g https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/sec-filings-8-k12g3 https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/sec-filings-ars https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/sec-filings-ct-order https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/sec-filings-def-14a https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/sec-filings-defr14a https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/sec-filings-pre-14a https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/sec-filings-prer14a https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/sec-filings-regdex https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/sec-filings-sc-14d9 https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/sec-filings-sc-to-c https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/sec-filings-sc-to-t https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/sec-filings-sc14d9c https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/secondary-offerings-form-effect https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/secondary-offerings-form-fwp https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/secondary-offerings-form-s-3mef https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/selling-and-marketing-expense https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/shareholders-equity https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/shares-authorized https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/shares-issued https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/short-term-investments https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/significant-purchase-commitment-remaining-minimum-amount-committed https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/stock-award-shares-issued-in-period https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/stock-based-compensation https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/stock-issued-new-shares-sold https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/stock-options-expirations-in-period https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/stock-options-grants-in-period https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/stock-options-outstanding-number https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/total-assets https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/total-liabilities https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/total-liabilities-and-equity https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/trading-securities https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/warrants-and-rights-outstanding https://stock.noler.com/us/stock/chelsea-therapeutics-international-ltd/weighted-average-number-of-share-outstanding-basic-and-diluted